AtriCure (ATRC) Fundamental Analysis: Revenue, Earnings & Valuation

9.90 / 10

Outperform

Fundamental analysis rates ATRC at 9.9/10, classifying it as Outperform. Profit‑MV scores high (group 1) and cash‑flow‑to‑revenue ratio is strong (10.7, group 3). Revenue‑MV and Asset‑MV are weak, but profit margins, ROA and EBIT ratios remain solid, supporting a robust financial profile.

Analysis Checks(7/10)

Revenue-MV

Value-0.58

Score0/3

Weight-386.88%

1M Return-4.18%

ROA (%)

Value-1.81

Score2/3

Weight71.29%

1M Return0.64%

Net cash flow from operating activities / Operating revenue (%)

Value10.73

Score2/3

Weight169.26%

1M Return1.48%

Profit-MV

Value0.66

Score2/3

Weight365.39%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-1.81

Score2/3

Weight71.29%

1M Return0.64%

EBIT / Total operating revenue (%)

Value-1.64

Score2/3

Weight10.93%

1M Return0.10%

Asset-MV

Value-0.55

Score1/3

Weight39.02%

1M Return0.38%

Net profit / Total operating revenue (%)

Value-2.14

Score3/3

Weight162.68%

1M Return1.41%

Cash-MV

Value-1.08

Score1/3

Weight-346.37%

1M Return-4.16%

Net profit / Total profit (%)

Value112.64

Score2/3

Weight-56.61%

1M Return-0.54%

Is ATRC undervalued or overvalued?

ATRC scores 9.90/10 on fundamentals and holds a Discounted valuation at present. Backed by its -2.40% ROE, -2.14% net margin, -123.18 P/E ratio, 2.87 P/B ratio, and 74.74% earnings growth, these metrics solidify its Outperform investment rating.